These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9178910)
21. Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer. Rimessi P; Gualandi F; Morelli C; Trabanelli C; Wu Q; Possati L; Montesi M; Barrett JC; Barbanti-Brodano G Oncogene; 1994 Dec; 9(12):3467-74. PubMed ID: 7970706 [TBL] [Abstract][Full Text] [Related]
22. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression. Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773 [TBL] [Abstract][Full Text] [Related]
23. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738 [TBL] [Abstract][Full Text] [Related]
24. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells. Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673 [TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells. Wang NP; To H; Lee WH; Lee EY Oncogene; 1993 Feb; 8(2):279-88. PubMed ID: 8426737 [TBL] [Abstract][Full Text] [Related]
26. Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site. Zenklusen JC; Hodges LC; LaCava M; Green ED; Conti CJ Oncogene; 2000 Mar; 19(13):1729-33. PubMed ID: 10763831 [TBL] [Abstract][Full Text] [Related]
27. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760 [TBL] [Abstract][Full Text] [Related]
28. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Shivapurkar N; Sood S; Wistuba II; Virmani AK; Maitra A; Milchgrub S; Minna JD; Gazdar AF Cancer Res; 1999 Aug; 59(15):3576-80. PubMed ID: 10446964 [TBL] [Abstract][Full Text] [Related]
29. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429 [TBL] [Abstract][Full Text] [Related]
30. Gene copy mapping of the ERBB2/TOP2A region in breast cancer. Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864 [TBL] [Abstract][Full Text] [Related]
31. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Chekmareva MA; Kadkhodaian MM; Hollowell CM; Kim H; Yoshida BA; Luu HH; Stadler WM; Rinker-Schaeffer CW Cancer Res; 1998 Nov; 58(21):4963-9. PubMed ID: 9810006 [TBL] [Abstract][Full Text] [Related]
32. Multiple pathways to cellular senescence: role of telomerase repressors. Oshimura M; Barrett JC Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109 [TBL] [Abstract][Full Text] [Related]
33. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Lerman MI; Minna JD Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536 [TBL] [Abstract][Full Text] [Related]
34. Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3' untranslated region mutations. Jupe ER; Liu XT; Kiehlbauch JL; McClung JK; Dell'Orco RT Cell Growth Differ; 1996 Jul; 7(7):871-8. PubMed ID: 8809404 [TBL] [Abstract][Full Text] [Related]
35. Functional evidence from microcell-mediated chromosome transfer of myeloid leukemia suppressor genes on human chromosomes 7 and 11. Wilding J; Meijne E; Haines J; Moody J; Edwards A; Newbold RF; Parris C; Cox R; Silver A Genes Chromosomes Cancer; 2002 Aug; 34(4):390-7. PubMed ID: 12112528 [TBL] [Abstract][Full Text] [Related]
36. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2. Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883 [TBL] [Abstract][Full Text] [Related]
37. Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer. Kruzelock RP; Cuevas BD; Wiener JR; Xu FJ; Yu Y; Cabeza-Arvelaiz Y; Pershouse M; Lovell MM; Killary AM; Mills GB; Bast RC Oncogene; 2000 Dec; 19(54):6277-85. PubMed ID: 11175342 [TBL] [Abstract][Full Text] [Related]
38. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8. Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene. Liscia DS; Morizio R; Venesio T; Palenzona C; Donadio M; Callahan R Br J Cancer; 1999 May; 80(5-6):821-6. PubMed ID: 10360661 [TBL] [Abstract][Full Text] [Related]
40. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]